| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |